Discontinuation report INVIRASE

Last updated on 2021-01-20 History
Report ID 132101
Drug Identification Number 02279320
Brand name INVIRASE
Common or Proper name PrINVIRASE® (saquinavir mesylate) 500 mg
Company Name HOFFMANN-LA ROCHE LIMITED
Market Status CANCELLED POST MARKET
Active Ingredient(s) SAQUINAVIR
Strength(s) 500MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size Glass or plastic (HDPE) bottles- 270 capsules
ATC code J05AE
ATC description DIRECT ACTING ANTIVIRALS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2020-12-31
Actual discontinuation date 2021-01-05
Remaining supply date 2021-06-30
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply No remaining supply discontinued as of January 2021.
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 7070 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 5M8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2021-01-20 English Compare
v2 2021-01-20 English Compare
v3 2021-01-20 French Compare
v4 2021-01-20 French Compare

Showing 1 to 4 of 4